Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trieber, C. A.
Right arrow Articles by Weiner, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trieber, C. A.
Right arrow Articles by Weiner, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 44, Issue of November 1, 1996 pp. 27339-27345
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Consequences of Removal of a Molybdenum Ligand (DmsA-Ser-176) of Escherichia coli Dimethyl Sulfoxide Reductase*

(Received for publication, February 5, 1996, and in revised form, August 7, 1996)

Catharine A. Trieber Dagger , Richard A. Rothery and Joel H. Weiner §

From the Department of Biochemistry and the Medical Research Council Group in the Molecular Biology of Membranes, University of Alberta, Edmonton, Alberta T6G 2H7, Canada

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

We have used site-directed mutagenesis and EPR spectroscopy to examine the consequences of altering the molybdenum ligand in Escherichia coli dimethyl sulfoxide (Me2SO) reductase (DmsABC). Mutagenesis of DmsA-Ser-176 to Ala, Cys, or His abolishes both respiratory growth on Me2SO and in vitro benzyl viologen:Me2SO oxidoreductase activity. EPR spectroscopy reveals changes in the line shape and the gav of the Mo(V) signals of the S176A and S176C enzymes. The midpoint potentials (Em,7) of the Mo(VI)/Mo(V) and Mo(V)/Mo(IV) couples in DmsABC are -15 and -175 mV. The Em,7 of the Mo(V)/Mo(IV) couple in the S176A mutant is 35 mV; however, the Mo(V) species could not be further oxidized with ferricyanide. Titration of the S176C mutant produced several overlapping Mo(V) species occurring at Eh > -150 mV, suggesting heterogeneity in the molybdenum environment. A Mo(V) spectrum was not visible in S176H membranes poised between -435 to 350 mV or oxidized with 200 µM ferricyanide. No differences were detected in the EPR spectra of the reduced [4Fe-4S] clusters of DmsABC and the S176A and S176H mutant enzymes; however, the S176C mutation altered the EPR line shape of one of the reduced [4Fe-4S] clusters.


INTRODUCTION

Dimethyl sulfoxide (Me2SO) reductase (DmsABC)1 of Escherichia coli is a membrane-bound terminal reductase that supports anaerobic respiratory growth on Me2SO (1, 2). It is a complex molybdenum-molybdopterin guanine dinucleotide (Mo-MGD) cofactor and [Fe-S] cluster-containing enzyme located on the cytoplasmic surface of the plasma membrane (3, 4). DmsA (87.4 kDa) is the largest subunit and binds Mo-MGD at its active site (5). DmsB (23.1 kDa) is the electron transfer subunit and ligates four [4Fe-4S] clusters (6, 7, 8, 9). DmsC (30.8 kDa) is an integral membrane protein that anchors the DmsAB subunits to the membrane and is necessary for menaquinol oxidation (9, 10). DmsABC belongs to a family of molybdenum-containing oxidoreductase enzymes with highly conserved organization and sequence (1, 11, 12, 13). These are prokaryotic enzymes that reduce Me2SO (11, 14, 15), trimethylamine N-oxide (16), nitrate (17, 18, 19, 21, 24, 25),234 biotin sulfoxide (14, 26, 27),5 polysulfide (29), and thiosulfate (30) or oxidize formate (31, 32, 33, 34, 35). These enzymes all bind molybdenum cofactor, specifically Mo-MGD, in the enzymes that have been characterized (5, 36). The cofactor from one of the enzymes in this family, the periplasmic Me2SO reductase (DMSR) from Rhodobacter sphaeroides, has been shown to be a bis-(MGD)-Mo (37), and the crystal structure of this enzyme has also recently been reported (38).

There are several forms of molybdenum cofactors that all consist of a molybdenum atom (or a tungsten in some cases) associated with molybdopterin mono- or dinucleotide (36). The molybdenum is proposed to be coordinated by the two dithiolene sulfur atoms of the molybdopterin (36), and this coordination of the molybdenum has been confirmed by the x-ray structures of three molybdopterin cofactor-containing enzymes (38, 39, 40). Pyrococcus furiosus aldehyde ferredoxin oxidoreductase contains a bis-molybdopterin-tungsten cofactor in which the tungsten is bound by the four dithiolene sulfurs of the molybdopterins, and an additional two coordination sites are occupied by oxo groups, glycerol from the buffer, or both (39). No ligands of the tungsten are from the protein. Aldehyde oxidoreductase from Desulfovibrio gigas contains a molybdopterin cytidine dinucleotide-Mo cofactor (40). The molybdenum is five coordinate with two sites occupied by the dithiolene sulfurs and three oxygen ligands. Two of the oxygen ligands are presumably oxo groups, and the third may come from the protein (40). In the crystal structure of the Rh. sphaeroides DMSR (38), molybdenum ligation is provided by the four dithiolene sulfurs of the molybdopterins, an oxo group, and a Ser residue (Ser-147).

The structure of Rh. sphaeroides DMSR is the most closely related to E. coli DmsA. DMSR is a soluble, periplasmically localized enzyme that receives reducing equivalents from periplasmically localized c-type cytochromes rather than from other subunits of a membrane-bound heterotrimer. However, comparison of the sequence of the E. coli DmsA subunit and the Rh. sphaeroides enzyme suggests a structural and functional similarity (54.4% similarity and 32% identity) between the two enzymes. In DMSR, the direct ligand to the molybdenum (Ser-147) is located in a highly conserved region of protein sequence within the family of bacterial molybdoenzymes that reduce S- and N-oxides (Fig. 1) (13, 42). Previous EXAFS studies of DMSR suggested that the molybdenum ligation sphere included four sulfur atoms, presumably from the two MGDs, one oxo ligand, and one oxygen or nitrogen ligand (41), in good agreement with the crystallographic data. The putative molybdenum ligand in the sequence of DmsA is Ser-176 on the basis of the sequence alignment. Molybdenum ligation by selenocysteine in E. coli formate dehydrogenase H (FdhF) has been identified by using a combination of site-directed mutagenesis, isotope enrichment, and EPR (42). However, the similarity between the region encompassing the molybdenum ligand in FdhF and that in DmsA is significantly weaker than the similarity between DmsA and other S- and N-oxides, including Rh. sphaeroides DMSR (Fig. 1) (13, 42). Molybdenum ligation by E. coli nitrate reductase (NarGHI) has been studied by EXAFS, and it has been suggested that sulfur and at least one oxo group are located in the molybdenum coordination sphere (43). In the sequence of the cofactor binding subunit of NarGHI, NarG, a Cys is found at the position occupied by a Ser in the N- and S-oxide reductases and the position occupied by a selenocysteine in FdhF (Fig. 1) (13), consistent with one of the sulfurs in the ligation sphere being from this Cys residue. Overall, there appears to be good agreement between the crystallographic and spectroscopic data on the nature of the molybdenum ligation sphere in the bacterial molybdoenzymes.


Fig. 1. Sequence alignment of the putative molybdenum binding sequence of bacterial molybdoenzymes. Shown are Rh. sphaeroides DMSR (Rs DMSR) (15, 56), E. coli DmsA (Ec DmsA) (11), Haemophilus influenzae (Hi) DmsA (14), E. coli (Ec) BisC (26), E. coli BisZ (28), H. influenzae BisC (14), E. coli TorA (16), Rh. sphaeroides (Rs) BisC (27), E. coli FdhF (35), and E. coli NarG (17). Se-Cys is denoted by a U in the E. coli FdhF sequence. The residues proposed to ligate the molybdenum in the enzymes (42) are shown in bold.
[View Larger Version of this Image (46K GIF file)]


In this paper, we have used site-directed mutagenesis and EPR spectroscopy to examine the role of Ser-176 of DmsA in molybdenum ligation. This residue was mutated to either an Ala, which could not provide a ligand to the molybdenum, or Cys, or His, both of which could potentially coordinate the molybdenum. All three mutant enzymes lack both physiological and artificial Me2SO reductase activity. EPR spectroscopy indicates that significant changes are elicited in the molybdenum coordination sphere by mutation of Ser-176.


EXPERIMENTAL PROCEDURES

Bacterial Strains and Plasmids

E. coli HB101(supE44 hsdS20 (rB-mB-) recA13 ara-14 proA2 lacY1 galK2 rpsL20 xyl-5 mtl-1) was used for expression of wild-type and mutant DmsABC. E. coli TG1 (supE hsdDelta 5 thi Delta (lac-proAB) F'[traD36 proAB+ lacIq lacZDelta M15]) was used for routine DNA manipulation (obtained from Amersham Corp.). DSS301 is a derivative of TG1 carrying a deletion of the entire dmsABC operon (10) and was used to test the ability of mutant DmsABC to support anaerobic respiratory growth on Me2SO. The plasmids used were the vector pBR322 (Pharmacia Biotech, Inc.), pDMS160 which contains the dms operon cloned into pBR322, and pDMS223 which has the dms operon cloned into pTZ18R (Pharmacia) (7).

Materials

Synthesis of oligonucleotides and DNA sequencing were carried out in the Department of Biochemistry DNA Core facility at the University of Alberta using an Applied Biosystems model 392 DNA synthesizer and a model 373A DNA sequencer (Perkin-Elmer). Restriction endonucleases and modifying enzymes were obtained from Life Technologies Inc., and the Sculptor in vitro mutagenesis kit was obtained from Amersham Corp. All other materials were reagent grade and were obtained from commercial sources.

Site-directed Mutagenesis

Manipulations of strains and plasmids were carried out as described by Sambrook et al. (44). The mutants of the dmsA Ser-176 codon were generated through oligonucleotide-directed mutagenesis of single-stranded pDMS223 DNA using the Sculptor kit and mutagenic primers, which substituted the Ser codon (TCC) for Ala (GCC), Cys (TGC), or His (CAC). Mutants were sequenced, subcloned into pDMS160 using EcoRI and EcoRV, and resequenced to confirm the mutation.

Growth of Bacteria

For growth experiments, DSS301 containing the appropriate plasmids were grown anaerobically on glycerol-Me2SO (2) media in 160-ml flasks. HB101 harboring the appropriate plasmid was grown anaerobically at 37 °C in 19-liter batches on glycerol/fumarate medium supplemented with 5 µM ammonium molybdate for 48 h (2). Final concentrations of antibiotics used were 100 µg ml-1 of ampicillin and streptomycin, 40 µg ml-1 of kanamycin.

Harvesting of Cells and Preparation of Membrane Fractions

For membrane preparations, glycerol/fumarate-grown cells were harvested, washed, and resuspended in 50 mM MOPS, pH 7.0, 5 mM EDTA. Phenylmethanesulfonyl fluoride (0.2 mM) was added to washed cells that were subjected to French pressure lysis and centrifugation for 1 h at 40,000 rpm in a Beckman Ti50.2 rotor (2). The membranes were washed with 100 mM MOPS, pH 7.0, 5 mM EDTA and resuspended in the same buffer. Membranes were stored at -70 °C prior to use.

Protein Determination

Protein concentrations were estimated by a modification of the Lowry procedure (45) using a Bio-Rad bovine serum albumin protein standard.

Enzyme Assays

The ability of the mutant DmsABC enzymes to oxidize reduced benzyl viologen (BV⨥) in a Me2SO- or TMAO- dependent manner was assayed as described previously (6). One unit of specific activity corresponds to 1 µmol of BV⨥ oxidized min-1 mg-1 protein.

Quantitation of Molybdenum and Molybdopterin

The amount of molybdenum present in the membrane preparations containing overexpressed enzymes was determined by Alpha Laboratory Services (Edmonton, Canada) by wet ashing the samples and inductively coupled plasma spectroscopy. The presence and relative amounts of molybdopterin present in the samples were determined using the Form A assay (46). 20 mg of membrane protein were acidified with HCl, 2 volumes of 2% KI, 1% I2 were added, and the sample was boiled for 20 min. Samples were centrifuged, and the supernatant was analyzed by fluorescence spectroscopy (5).

EPR Spectroscopy

Redox titrations of washed membranes were carried out as described by Cammack and Weiner (6) using sodium dithionite and potassium ferricyanide to alter the redox potential. The mediators used in the redox titrations were quinhydrone, 2,6-dichlorophenolindophenol, 1,2-naphthoquinone, toluylene blue, phenazine methosulfate, thionine, duroquinone, methylene blue, resorufin, indigotrisulfonate, indigo carmine, anthraquinone 2-sulfonic acid, benzyl viologen, and methyl viologen. Spectra were recorded using a Bruker ESP300 EPR spectrometer equipped with an Oxford Instruments ESR-900 flowing helium cryostat. Instrument conditions and temperatures are described in the individual figure legends. Spin quantitations were determined by double integration of spectra obtained under nonsaturating conditions using a Cu-EDTA standard (47). For the molybdenum quantitations an additional correction was made to account for not integrating the hyperfine lines due to molybdenum with a nuclear spin of 5/2 (48).


RESULTS

Characterization of the Ser-176 Mutants

E. coli DSS301 is unable to grow anaerobically on glycerol-Me2SO medium unless complemented with a plasmid containing the dmsABC operon. None of the three mutant enzymes, expressed in DSS301, are able to support growth using Me2SO as the terminal electron acceptor (Table I). HB101 contains a wild-type copy of the dmsABC operon on the chromosome and grows on glycerol-Me2SO, but this growth is completely inhibited when this strain is transformed with the Ser-176 mutant plasmids (data not shown). Plasmid-expressed enzyme competes for membrane assembly with the small amount of enzyme produced from the chromosomal operon, a phenomenon that has been noted in previous studies of DmsABC mutant enzymes (7, 49). The expression (Table II) and membrane localization of the mutant enzymes are normal compared with the wild type. DmsABC oxidizes BV⨥ in a TMAO- or Me2SO-dependent manner (Table I). This ability is reduced to a level much lower than that of the background (HB101/pBR322) in the mutant enzymes, indicating that catalytically inactive plasmid-encoded enzyme is competing with active chromosomally-encoded enzyme. HB101 was chosen as the host for expression of DmsABC, rather than DSS301, due to the large amounts of fumarate reductase in DSS301 membranes that interferes with EPR analyses (7, 9).

Table I.

Enzyme activities of membranes containing amplified levels of wild-type and mutant DmsABC


Plasmid Growtha Specific activitiesb
BV&+cjs0744;:TMAO BV&+cjs0744;:Me2SO TMAO/Me2SO

pBR322 NG 16  ± 1 1.5  ± 0.2 10.7
pDMS160 + 96  ± 10 10  ± 2 9.6
pS176A NG 3.6  ± 0.8 0.4  ± 0.1 9
pS176C NG 3.1  ± 0.5 0.36  ± 0.07 8.6
pS176H NG 2.8  ± 0.8 0.29  ± 0.03 9.7

a  Growth of plasmid containing DSS301 was determined from measurements of turbidity in glycerol/Me2SO medium using a Klett-Summerson spectrophotometer. NG, no growth; +, growth.
b  Washed membranes were prepared from HB101 cells grown on glycerol/fumarate medium. Activities are expressed in units of µmol of BV&+cjs0744; oxidized min-1 mg-1 protein.

Table II.

Spin quantitation and midpoint potentials of the EPR signals from HB101 expressing wild-type or mutant DmsABC


Membrane sample Signal intensities
Normalized fluorescenced Midpoint potentials, Em,7
Enzymea Mo(V)b Total Moc Mo(VI)/Mo(V) Mo(V)/Mo(IV)

nmol mg-1 protein mV
DmsABC 0.40 0.32 0.39 0.39  -15  -175
S176A 0.45 0.41 0.44 0.39  ---e 35
S176C 0.41 0.16 0.32 0.34 27, 34f  -7, -33
S176H 0.38  --- 0.27 0.25  ---  ---

a  [Fe-S] concentrations were estimated by double integration of spectra of dithionite-reduced membrane samples obtained at 12 K and 2 mW. The concentration of [Fe-S] was divided by 4 to estimate the concentration of enzyme.
b  Molybdenum concentrations were estimated from spectra obtained at 95 K under the following nonsaturating conditions: DmsABC, -91 mV and 20 mW; S176A, 351 mV and 2 mW; S176C, 23 mV and 2 mW.
c  The total amount of molybdenum in the membrane preparations was determined by inductively coupled plasma emission spectroscopy.
d  Form A-pterin fluorescence at an emission wavelength of 455 nm with an excitation wavelength of 380 nm. Fluorescence intensities in arbitrary units are normalized to the molybdenum content of membranes containing wild-type DmsABC.
e  ---, no value given.
f  S176C midpoint potentials given are for the g = 1.992 peak and the g = 1.985 peak-trough.

All three mutant enzymes contain both molybdenum and molybdopterin (Table II); the amount of molybdenum in the enzyme varied among the different preparations. The wild-type enzyme and the S176A mutant have essentially one molybdenum atom per mol of enzyme, but the amount of molybdenum relative to enzyme is decreased in the S176C and S176H mutants. S176C has 0.78 mol of molybdenum per mol of enzyme, whereas S176H has 0.71 mol of molybdenum per mol of enzyme. The relative amount of fluorescence detected in the Form A assays of each of the enzyme preparations parallels that of the molybdenum concentration, with S176A having wild-type levels of molybdopterin, whereas S176C and S176H have reduced levels of molybdopterin. This agrees with previous studies of DmsABC that indicate that molybdopterin is not inserted into DmsA in the absence of molybdenum (5).

Mo(V) EPR Spectra in the Wild-type and Mutant Enzymes

Fig. 2 shows EPR spectra recorded at 95 K of membranes from HB101 harboring control or mutant plasmids. The spectrum of Mo(V) in DmsABC membranes poised at -91 mV (Fig. 2A) is identical to that previously characterized in membranes and purified DmsABC preparations (6). The line shape indicates rhombic symmetry with g values of 1.982, 1.978, and 1.957; the gav = 1.972 and the g1-g3 = 0.025. The spectrum is similar to the high pH Mo(V) signal of E. coli nitrate reductase (6, 50). Because the redox chemistry of the molybdenum in the Ser-176 mutants differs significantly from the wild type (see below), ferricyanide was used to generate samples of the mutants containing Mo(V). EPR spectra of Mo(V) from the mutant enzymes (Fig. 2, B-D) are dramatically different compared with the wild type (Fig. 2A). The S176A Mo(V) signal is much more anisotropic (g1-g3 = 0.057) with g values at 2.018, 1.982, and 1.961 (gav = 1.987). The S176C ferricyanide-oxidized signal (g1, 2, 3 = 2.028, 1.993, and 1.983) has a g1-g3 = 0.045, and a gav = 2.013. A Mo(V) spectrum is not observed in ferricyanide-oxidized S176H membranes (Eh >400 mV) (Fig. 2D) or throughout the Eh range studied herein (see below).


Fig. 2. Mo(V) EPR spectra of HB101 membranes. a, HB101/pDMS160; b, HB101/pS176A; c, HB101/pS176C; and d, HB101/pS176H. Sample a, was poised at -91 mV during a redox titration. Samples b--d were incubated at 25 °C with 200 µM ferricyanide for 10 min before freezing in liquid nitrogen. Spectra were recorded under the following conditions: temperature, 95 K; microwave power, 20 mW; microwave frequency, 9.45 GHz; modulation amplitude, 3.02 Gpp at 100 KHz. Spectra were corrected for the amount of enzyme present as determined from spin quantitations (Table II).
[View Larger Version of this Image (15K GIF file)]


Redox Titration of the Wild-type DmsABC Mo(V) Signal

Redox titrations of DmsABC and the Ser-176 mutant enzymes were carried out to determine the midpoint potentials of the Mo(VI)/Mo(V) and Mo(V)/Mo(IV) couples. A titration of the wild-type enzyme is shown in Fig. 3A. Of the three oxidation states through which the molybdenum cycles, only Mo(V) is paramagnetic so the titration curve shows the appearance and disappearance of this intermediate oxidation state. The DmsABC Mo(V) signal appears at approximately -250 mV, increases to a maximum at -91 mV, and then decreases until, at approximately 85 mV, it is no longer visible. The data from the titration can be fitted to a model of the Nernst equation with two consecutive midpoint potentials (Em,7) for the reduction of Mo(VI)/Mo(V) and Mo(V)/Mo(IV). The Em,7 of the Mo(VI)/Mo(V) couple is -15 mV, and the Em,7 of the Mo(V)/Mo(IV) couple is -175 mV, with an average of -95 mV. The amount of Mo(V) estimated by double integration of the spectrum of the Eh = -91 mV sample and the total amount of molybdenum present are shown in Table II. In DmsABC, approximately 80% of the total molybdenum was EPR visible at -91 mV.


Fig. 3. Redox titration curves of the Mo(V) signals in HB101 membranes. A, the change in signal amplitude is plotted as a function of redox potential for the g = 1.982 signals of HB101/pDMS160 (squares) and HB101/pS176A (diamonds) membranes. B, the change in signal amplitude of the g = 1.992 peak (circles) and the g = 1.985 peak-trough (triangles) of the HB101/pS176C membranes is plotted as a function of redox potential. Spectra were recorded under the conditions outlined in Fig. 2.
[View Larger Version of this Image (19K GIF file)]


Redox Titrations of the Mo(V) Signals in the Ser-176 Mutants

In redox titrations of S176A membranes, the Mo(V) signal appears at approximately -50 mV and increases to a maximum intensity above 125 mV (Fig. 3A). The appearance of the Mo(V) EPR signal of the S176A mutant can be fitted to a single midpoint potential of 35 mV. At least 90% of the molybdenum is oxidized to Mo(V), which even at 200 µM ferricyanide (spectrum shown in Fig. 2B) remained in the Mo(V) state.

Spectra from a redox titration of the S176C membranes are shown in Fig. 4. Analyses of redox titrations of the S176C mutant indicate that several Mo(V) species are present. The two largest features, a peak at g = 1.992 and a peak-trough at g = 1.985, behave independently, indicating that they arise from different species. The redox titration curves for these two features are shown in Fig. 3B and the midpoint potentials are in Table II. Integration of the Eh = 24 mV spectrum indicates that, at this potential, the spectrum dominated by the g = 1.992 species accounted for 40% of the total molybdenum in this enzyme. The Eh = 346 mV spectrum in Fig. 4 is not equivalent to the ferricyanide oxidized-spectrum in Fig. 2C, suggesting that the high Eh induced by ferricyanide may cause the appearance of an additional Mo(V) species not observed during potentiometric redox titrations.


Fig. 4. Spectra of HB101/pS176C membranes during oxidative titration. Spectra were recorded as described in Fig. 2.
[View Larger Version of this Image (16K GIF file)]


The S176H membranes were titrated over a range of Eh from -435 to 350 mV, but a Mo(V) signal was not detected. Fluorescence analyses of molybdopterin content and analyses of molybdenum content (Table II) indicate that all of the mutant enzymes contain a similar amount of Mo-MGD. Thus, in the case of the S176H mutant, the paramagnetic Mo(V) redox state appears to be inaccessible.

EPR Spectra of Dithionite-reduced Membranes

HB101 membrane preparations were reduced with dithionite and EPR spectra recorded at 12 K to examine the [4Fe-4S] clusters in the mutant enzymes (Fig. 5). The background strain, HB101/pBR322, expresses very little DmsABC, and the spectrum shows primarily the features of fumarate reductase (8, 51). The spectrum of HB101/pDMS160 membranes is identical to that of DmsABC in membranes as previously characterized and has been interpreted as two pairs of interacting [4Fe-4S] clusters (Em,7 = -50, -120, -240, and -340 mV) (6, 7, 8, 9). The spectrum contains peaks at g = 2.05, 2.03, 1.99, and 1.95 and two troughs located at g = 1.92 and g = 1.88. Fumarate reductase contributes to the peak at g = 2.03 and the peak-trough at g = 1.95 to g = 1.92. The reduced spectra of the S176A and S176H mutants are very similar to the wild-type spectrum. However, the line shape of the S176C spectrum (Fig. 5D) is altered; the peaks at g = 2.05 and g = 1.95 are increased in size, and the g = 1.94 shoulder is more distinct. The content of [Fe-S] clusters is not increased in this mutant, and only four phases are present in analyses of the g = 2.05 and g = 1.95 features from redox titrations of S176C membranes indicating that all four [4Fe-4S] clusters are present. The midpoint potential of the Em,7 = -240 mV [4Fe-4S] cluster appears to be shifted to a more positive potential in this mutant (>100mV more positive, data not shown). The extent of this change in Em,7 could not be accurately quantified because the Mo(V) interacts magnetically with the reduced [Fe-S] clusters (6), modifying their spectra, and complicating assignments of their Em,7 values. These observations indicate that there is a possible conformational link between the Em,7 = -240 mV [4Fe-4S] cluster of DmsB and the molybdenum binding region of DmsA.


Fig. 5. Spectra of the reduced membranes at 12 K. a, HB101/pBR322; b, HB101/pDMS160; c, HB101/pS176A; d, HB101/pS176C; and e, HB101/pS176H. Samples were incubated under argon for 2 min prior to the addition of 5 mM dithionite. After a further incubation of 10 min, samples were frozen in liquid nitrogen. Spectra are recorded under the following conditions: temperature, 12 K; microwave power, 20 mW; microwave frequency, 9.45 GHz; modulation amplitude, 10 Gpp at 100 KHz. Spectra were corrected to an arbitrary protein concentration of 30 mg ml-1.
[View Larger Version of this Image (13K GIF file)]



DISCUSSION

DmsA is the catalytic subunit of E. coli Me2SO reductase and contains a Mo-MGD cofactor. It belongs to a family of prokaryotic molybdoenzyme subunits that share sequence homology and probably ligate the same molybdopterin cofactor (1, 13). The determination of the crystal structure of Rh. sphaeroides DMSR (38) and a variety of biophysical studies have provided insights into the nature of the molybdenum ligation in this group of enzymes (41, 42, 43). Aided by sequence alignments (Fig. 1) and the crystal structure of DMSR (38), we have mutated a ligand of molybdenum in DmsA. Mutation of Ser-176 has a profound effect both on the EPR line shape and the redox properties of the molybdenum. In the case of the S176A mutant, the molybdenum is trapped in the Mo(V) state at high Eh. Substituting Cys at this position causes a heterogeneity in the molybdenum environment and also appears to affect at least one of the [Fe-S] clusters. Substituting His prevents the appearance of Mo(V) throughout the range of Eh studied. Overall, the effects of mutating Ser-176 are consistent with its proposed role in molybdenum ligation.

Mutating Ser-176 to Ala increases the gav and the g1-g3 of the Mo(V) EPR spectrum. Chicken liver sulfite oxidase exhibits low and high pH Mo(V) spectra (52, 53). The high pH Mo(V) species has a higher gav and g1-g3 than the low pH species, in a manner similar to the wild-type and S176A Mo(V) species studied herein. EXAFS has been used to correlate the line shape change between the low and high pH forms of sulfite oxidase species with a loss of a molybdenum ligand (53). It is likely, given these studies on sulfite oxidase, and taking into consideration the molybdenum ligation sphere of the Rh. sphaeroides DMSR revealed by x-ray crystallography, that the line shape change elicited by the S176A mutation in DmsA is the result of the loss of a molybdenum ligand, Ser-176.

In terms of interpreting the effects of the mutation on the Mo(V) EPR line shape, the situation with the S176C mutant is complicated by the multiple species detected. There is a large difference between the high Eh ferricyanide-oxidized species and the two major species observed at lower Eh values in potentiometric tritrations. The difference between the two low Eh species and the high Eh species is reminiscent of the difference between the wild-type and the S176A mutant. It is therefore possible that the high Eh S176C species has fewer ligands than the low Eh species. An explanation for this stems from the conformation changes observed in the pterin dithiolene ligation of the molybdenum in Rh. sphaeroides DMSR. Of the two pterin dithiolenes, one (the Q-pterin) interacts less strongly than the other (the P-pterin) (38). It is possible that a subpopulation of the Cys of the S176C mutant is able to form a disulfide bridge with one of the Q-pterin dithiolene sulfurs, preventing direct ligation of the molybdenum, resulting in the high gav, high g1-g3 line shape. At low Eh, only the forms with a Cys ligand to the molybdenum would be observed, and these would be observed in potentiometric titrations. Comparison of Fig. 2C and Fig. 4 (346 mV spectrum) suggests that the putative disulfide bond may become reduced under anaerobic reducing conditions, as the high Eh ferricyanide-oxidized species is not observed in redox titrations at high Eh.

Of the DmsA mutants, the S176H mutant is the most difficult to interpret, due to the absence of any EPR visible Mo(V) species detected in our studies. We had anticipated that possible nitrogen ligation of the molybdenum in this mutant would result in EPR spectra in which nitrogen hyperfine coupling would be observed. Unfortunately, we are unable to draw any conclusions concerning the molybdenum ligation sphere from this mutant; the only clear result is that the redox potentials of the molybdenum are shifted, so that a Mo(V) species is not observed in the Eh range studied.

In the other bacterial molybdoenzyme for which molybdenum ligand mutagenesis data are available, E. coli FdhF, a Se-Cys has been shown to be a molybdenum ligand (42). Enrichment of the enzyme with 77Se (I = 1/2) causes hyperfine splitting of the Mo(V) EPR signal indicating a direct coordination of selenium to the molybdenum. Mutagenesis of FdhF to replace the Se-Cys with Cys causes a major change in the line shape and the g values of the Mo(V) signal: both the gav and the anisotropy (g1-g3) are decreased. Changes in EPR parameters resulting from a change in the coordination of the molybdenum are also observed in the molybdenum hydroxylases when comparing the native and desulfo forms of the enzymes (54). The native enzymes have one oxo and one sulfhydryl ligand to Mo(V), which becomes one oxo and one hydroxyl ligand in the inactive desulfo forms. Comparison of Mo(V) signals indicates that replacement of the sulfhydryl ligand with a hydroxyl group decreases the gav and the g1-g3 (54, 55). Conversely, replacing an oxygen ligand with a sulfur ligand should increase the gav and the g1-g3. In potentiometric titrations of the S176C mutant (Fig. 4), the apparent gav is increased compared to the wild-type Mo(V) spectrum (Fig. 2A).

Comparisons of the electrochemical and EPR properties of the molybdenum of DmsA and DMSR reveal two important differences between the two enzymes. First, in DMSR, the Em,7 of the Mo(VI/V) (Em,7 = 200 mV) and Mo(V/IV) (Em,7 = 141 mV) couples are more appropriate for Me2SO (Em,7 = 160 mV) reduction than is the case for DmsA (20). Second, DMSR has been shown to contain a coupled proton to the molybdenum that is observable through hyperfine splittings of the Mo(V) EPR spectrum (20). Such a proton has not been observed in DmsA (6). In Rh. sphaeroides DMSR, the structure of the enzyme reveals a Tyr residue (Tyr-114) that provides a hydrogen bond to the oxo group of the Mo=O moiety of the oxidized enzyme. There is no equivalent Tyr in the sequence of DmsA (38), and the identity of potential amino acid residues providing a hydrogen bond to the oxo group is currently unknown. It is not clear if the Tyr of DMSR is implicated in the observation of a coupled proton in this enzyme. The differences in electrochemical and EPR properties between the two enzymes will probably be rationalized through site-directed mutagenesis studies of amino acid residues close to the molybdenum and the MGDs.

The Em,7 of the Mo(V)/Mo(IV) couple in the S176A mutant is 35 mV, 210 mV more positive than that of the wild-type Mo(V)/Mo(IV) couple, Em,7 = -175 mV. The enzyme is trapped in the Mo(V) state at Eh values increasing to 450 mV. Thus, in the S176A mutant the molybdenum is unable to transfer two electrons to Me2SO, and this is probably a major cause of this mutant's inability to catalyze Me2SO reduction.

Several different Mo(V) species were detected in redox titrations of the S176C mutant. The two largest signals come from species with Em,7 values of 27 and 34 mV for the Mo(VI)/Mo(V) couples and Em,7 values of -7 and -33 mV for the Mo(V)/Mo(IV) couples. The Em,7 values of the individual species are closer together and shifted to a more positive potential than those of the wild-type enzyme but less than the S176A mutant. Comparison of the molybdenum Em,7 values of the S176C mutant indicates that the major species should be able to participate in Me2SO reduction, so it is unclear why this mutant is catalytically inactive.

The Cys substitution of Ser-176 also alters the line shape of the reduced [4Fe-4S] clusters as well. The molybdenum in DmsA is known to interact magnetically with the Em,7 = -120 mV [4Fe-4S] cluster of DmsB (6). The S176C mutation appears to affect the Em,7 = -240 mV [4Fe-4S] cluster indicating that this cluster may be near to Ser-176 in DmsABC. It is not known how the molybdenum center in DmsA becomes reduced, but the electrons may come sequentially from one [4Fe-4S] cluster or possibly from two [4Fe-4S] clusters (perhaps the Em, 7 = -120 and -240 mV centers). The Em,7 = -50 mV center has been implicated in interactions with a menaquinol binding site in DmsC (9). Little information is available about the Em,7 = -340 mV center which may play a structural role or could be involved in mediating electron transfer. Further studies on the [Fe-S] clusters and the Mo-MGD will be aimed at understanding these subunit interactions and electron transfer between the subunits.

No Mo(V) signal was visible in redox titrations of S176H, although the mutant enzyme has molybdopterin and molybdenum. The midpoint potentials of the S176H molybdenum center may be shifted to a higher potential than that of ferricyanide, as it is unlikely that they would be significantly less than -435 mV. The lowest midpoint potential determined for a molybdenum couple is -470 mV at pH 7.7 for Methanobacterium formicicum formate dehydrogenase (22).

The Em,7 values of the Mo(VI)/Mo(V) and Mo(V)/Mo(IV) couples are dependent on the molybdenum environment. In the native form of the molybdenum hydroxylases (oxygen and sulfur coordination), one or both Em values are higher than the Em values of the desulfo enzymes (oxygen coordination) (55). In the DmsA family of molybdoenzymes the identity of the ligand, Se-Cys, Cys, or Ser, may influence the redox properties of the molybdenum. The molybdenum midpoint potentials of a Se-Cys containing enzyme have not been determined but must be low to be able to catalyze the oxidation of formate (Em,7 = -425 mV for the formate/CO2 couple). DmsABC (Em,7 = -15 and -175 mV) and Me2SO reductase from Rh. sphaeroides (Em,7 = 144 and 200 mV (20)) have intermediate midpoint potentials and Ser coordination of the molybdenum. E. coli nitrate reductase (Cys residue) has Em values of 180 and 220 mV at pH 7.1 (23). The formate dehydrogenase from M. formicicum which has both a Cys and a sulfhydryl ligand (54) has the lowest Em of all the molybdoenzymes characterized, Em = -330 and -470 mV at pH 7.7 (22), indicating that other elements in the molybdenum environment are important for determining the molybdenum Em values.

The Em,7 values obtained from the titration of wild-type DmsABC in membranes are -15 mV for the Mo(VI)/Mo(V) couple and -175 mV for the Mo(V)/Mo(IV) couple, with an average of -95 mV. The Em,7 values determined in an earlier study of DmsABC containing membranes were -75 and -90 mV, with an average of -83 mV (6). In the previous study, the Em,7 values, but not the Mo(V) signal itself, were highly dependent upon the preparation of DmsABC and the ratio of Mo(V) to enzyme was 0.33. DmsABC loses cofactor during purification, and the purified enzyme retains approximately 30% of its Mo-MGD (5, 28). The amount of Mo(V) detected in membranes used for the current study accounts for over 80% of the molybdenum that should be present if each enzyme molecule has one molybdenum (Table II). Care has been taken in this study to avoid repeated freeze-thaw cycles and unnecessary manipulations to prevent the loss of molybdenum. In contrast to the previous study, these membranes did not exhibit a partial Mo(V) signal at potentials greater than 80 mV (6).

Overall, the data presented herein show the consequences of changing the Mo-protein ligand of E. coli DmsABC. Loss of ligation by DmsA-Ser176 causes major changes in the redox and EPR properties of the enzyme and the molybdenum center. The S176A mutant is unable to cycle through the Mo(V) left-right-arrow  Mo(VI) redox states. The S176C mutant causes significant heterogeneity of the molybdenum center, and in the S176H mutant the Mo(V) state is inaccessible. These studies provide new insights into the role of molybdenum ligation in bis-(MGD)-Mo-containing bacterial molybdoenzymes.


FOOTNOTES

*   This work was funded by the Medical Research Council of Canada through Medical Research Council Grant PG-11440. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Present address: Dept. of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7.
§   To whom correspondence should be addressed. Tel.: 403-492-2761; Fax: 403-492-0886; E-mail: joel.weiner{at}ualberta.ca.
1   The abbreviations used are: DmsABC, E. coli dimethyl sulfoxide reductase; BV⨥, reduced benzyl viologen; DMSR, Rh. sphaeroides Me2SO reductase; EPR, electron paramagnetic resonance; Mo-MGD, molybdenum-molybdopterin guanine dinucleotide cofactor; MOPS, 4-morpholinepropanesulfonic acid; TMAO, trimethylamine-N-oxide.
2   P. Richterich, N. Lakey, D. Gryan, L. Jaehn, L. Mintz, K. Robison, and G. M. Church, EMBL accession number U00008[GenBank].
3   M. Unthan, W. Klipp, and G. H. Schmid, (1995) EMBL accession number X89445[GenBank].
4   X. Andriesse and H. Bakker, EMBL accession number X74597[GenBank].
5   A. del Campillo-Campbell and A. M. Campbell, EMBL accession number U38839[GenBank].

REFERENCES

  1. Weiner, J. H., Rothery, R. A., Sambasivarao, D., Trieber, C. A. (1992) Biochim. Biophys. Acta 1102, 1-18 [CrossRef][Medline] [Order article via Infotrieve]
  2. Bilous, P. T., Weiner, J. H. (1985) J. Bacteriol. 162, 1151-1155 [Abstract/Free Full Text]
  3. Sambasivarao, D., Scraba, D. G., Trieber, C., Weiner, J. H. (1990) J. Bacteriol. 172, 5938-5948 [Abstract/Free Full Text]
  4. Rothery, R. A., Weiner, J. H. (1993) Biochemistry 32, 5855-5861 [CrossRef][Medline] [Order article via Infotrieve]
  5. Rothery, R. A., Simala Grant, J. L., Johnson, J. L., Rajagopalan, K. V., Weiner, J. H. (1995) J. Bacteriol. 177, 2057-2063 [Abstract/Free Full Text]
  6. Cammack, R., Weiner, J. H. (1990) Biochemistry 29, 8410-8416 [CrossRef][Medline] [Order article via Infotrieve]
  7. Rothery, R. A., Weiner, J. H. (1991) Biochemistry 30, 8296-8305 [CrossRef][Medline] [Order article via Infotrieve]
  8. Trieber, C. A., Rothery, R. A., Weiner, J. H. (1996) J. Biol. Chem. 271, 4620-4626 [Abstract/Free Full Text]
  9. Rothery, R. A., Weiner, J. H. (1996) Biochemistry 35, 3247-3257 [CrossRef][Medline] [Order article via Infotrieve]
  10. Sambasivarao, D., Weiner, J. H. (1991) J. Bacteriol. 173, 5935-5943 [Abstract/Free Full Text]
  11. Bilous, P. T., Cole, S. T., Anderson, W. F., Weiner, J. H. (1988) Mol. Microbiol. 2, 785-795 [CrossRef][Medline] [Order article via Infotrieve]
  12. Wootton, J. C., Nicolson, R. E., Cock, J. M., Waters, D. E., Burke, J. F., Doyle, W. A., Bray, R. C. (1991) Biochim. Biophys. Acta 1057, 157-185 [Medline] [Order article via Infotrieve]
  13. Berks, B. C., Ferguson, S. J., Moir, J. W. B., Richardson, D. J. (1995) Biochim. Biophys. Acta 1232, 97-123 [Medline] [Order article via Infotrieve]
  14. Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., F., K. E., Kerlavage, A. R., Bult, C. J., Tomb, J.-F., Dougherty, B. A., Merrick, J. M., McKenney, K., Sutton, G., Fitzhugh, W., Fields, C. A., Gocayne, J. D., Scott, J. D., Shirley, R., Liu, L.-I., Glodek, A., Kelley, J. M., Weidman, J. F., Phillips, S. C. A., Spriggs, T., Hedblom, E., Cotton, M. D., Utterback, T. R., Hanna, M. C., Nguyen, D. T., Saudek, D. M., Brandon, R. C., Fine, L. D., Fritchman, J. L., Fuhrmann, J. L., Geoghagen, N. S. M., Gnehm, C. L., McDonald, L. A., Small, K. V., Fraser, C. M., Smith, H. O., Venter, J. C. (1995) Science 269, 496-512 [Abstract/Free Full Text]
  15. Barber, M. J., Valkenburgh, H. V., Trimboli, A. J., Pollock, V. V., Neame, P. J., Bastian, N. R. (1995) Arch. Biochem. Biophys. 320, 266-275 [CrossRef][Medline] [Order article via Infotrieve]
  16. Méjean, V., Iobbi-Nivol, C., Lepelletier, M., Giordano, G., Chippaux, M., Pascal, M.-C. (1994) Mol. Microbiol. 11, 1169-1179 [Medline] [Order article via Infotrieve]
  17. Blasco, F., Iobbi, C., Giordano, G., Chippaux, M., Bonnefoy, V. (1989) Mol. Gen. Genet. 218, 249-256 [CrossRef][Medline] [Order article via Infotrieve]
  18. Blasco, F., Iobbi, C., Ratouchniak, J., Bonnefoy, V., Chippaux, M. (1990) Mol. Gen. Genet. 22, 104-111
  19. Siddiqui, R. A., Warnecke-eberz, U., Hengsberger, A., Schneider, B., Kostka, S., Friedrich, B. (1993) J. Bacteriol. 175, 5867-5876 [Abstract/Free Full Text]
  20. Bastian, N. R., Kay, C. J., Barber, M. J., Rajagopalan, K. V. (1991) J. Biol. Chem. 266, 45-51 [Abstract/Free Full Text]
  21. Berks, B. C., Richardson, D. J., Reilly, A., Willis, A. C., Ferguson, S. J. (1995) Biochem. J. 309, 983-992
  22. Barber, M. J., Siegel, L. M., Schauer, N. L., May, J. D., Ferry, J. G. (1983) J. Biol. Chem. 258, 10839-10845 [Abstract/Free Full Text]
  23. Vincent, S. P. (1979) Biochem. J. 177, 757-759 [Medline] [Order article via Infotrieve]
  24. Ogawa, K.-I., Akagawa, E., Yamane, K., W., S. Z., Lacelle, M., Zuber, P., Nakano, M. M. (1995) J. Bacteriol. 177, 1409-1413 [Abstract/Free Full Text]
  25. Lin, J. T., Goldman, B. S., Stewart, V. (1993) J. Bacteriol. 175, 2370-2378 [Abstract/Free Full Text]
  26. Pierson, D. E., Campbell, A. (1990) J. Bacteriol. 172, 2194-2198 [Abstract/Free Full Text]
  27. Pollock, V. V., Barber, M. J. (1995) Arch. Biochem. Biophys. 318, 322-332 [CrossRef][Medline] [Order article via Infotrieve]
  28. Weiner, J. H., MacIsaac, D. P., Bishop, R. E., Bilous, P. T. (1988) J. Bacteriol. 170, 1505-1510 [Abstract/Free Full Text]
  29. Krafft, T., Bokranz, M., Klimmek, O., Schröeder, I., Fahrenholz, R., Kojro, E., Kröger, A. (1992) Eur. J. Biochem. 206, 503-510 [Medline] [Order article via Infotrieve]
  30. Heinzinger, N. K., Fujimoto, S. Y., Clark, M. A., Moreno, M. S., Barrett, E. L. (1995) J. Bacteriol. 177, 2813-2820 [Abstract/Free Full Text]
  31. Berg, B. L., Li, J., Heider, J., Stewart, V. (1991) J. Biol. Chem. 266, 22380-22385 [Abstract/Free Full Text]
  32. Bokranz, M., Guttman, M., Kortnor, C., Kojro, F., Fahrenholz, F., Lauterbach, F., Kröger, A. (1991) Arch. Microbiol. 156, 119-128 [CrossRef][Medline] [Order article via Infotrieve]
  33. Plunkett, G. I., Burland, B. D., Daniels, D. L., Blattner, F. R. (1993) Nucleic Acids Res. 21, 3391-3398 [Abstract/Free Full Text]
  34. Shuber, A. P., Orr, E. C., Recny, M. A., Schendel, P. F., May, H. D., Schauer, N. L., Ferry, J. G. (1986) J. Biol. Chem. 261, 12942-12947 [Abstract/Free Full Text]
  35. Zinoni, F., Birkmann, A., Stadtman, T. C., Böck, A. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 4650-4654 [Abstract/Free Full Text]
  36. Rajagopalan, K. V., Johnson, J. L. (1992) J. Biol. Chem. 267, 10199-10202 [Free Full Text]
  37. Hilton, J. C., Rajagopalan, K. V. (1996) Arch. Biochem. Biophys. 325, 139-143 [CrossRef][Medline] [Order article via Infotrieve]
  38. Schindelin, H., Kisker, C., Hilton, J., Rajagopalan, K. V., Rees, D. C. (1996) Science 272, 1615-1621 [Abstract]
  39. Chan, M. K., Mukund, S., Kletzin, A., Adams, M. W. W., Rees, D. C. (1995) Science 267, 1463-1469 [Abstract/Free Full Text]
  40. Romao, M. J., Archer, M., Moura, I., Moura, J. J. G., LeGall, J., Engh, R., Schneider, M., Hof, P., Huber, R. (1995) Science 270, 1170-1176 [Abstract/Free Full Text]
  41. George, G. N., Hilton, J., Rajagopalan, K. V. (1996) J. Am. Chem. Soc. 118, 1113-1117 [CrossRef]
  42. Gladyshev, V. N., Khangulov, S. V., Axley, M. J., Stadtman, T. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7708-7711 [Abstract/Free Full Text]
  43. George, G. N., Turner, N. A., Bray, R. C., Morpeth, F. F., Boxer, D. H., Cramer, S. P. (1989) Biochem. J. 259, 693-700 [Medline] [Order article via Infotrieve]
  44. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  45. Markwell, M. A. D., Haas, S. M., Bieber, L. L., Tolbert, N. E. (1978) Anal. Biochem. 87, 206-210 [CrossRef][Medline] [Order article via Infotrieve]
  46. Johnson, J. L., Indermauer, L. W., Rajagopalan, K. V. (1991) J. Biol. Chem. 266, 12140-12145 [Abstract/Free Full Text]
  47. Paulsen, K. E., Stankovich, M. T., Orville, A. M. (1993) Methods Enzymol. 227, 396-411 [Medline] [Order article via Infotrieve]
  48. Barber, M. J., Bray, R. C., Lowe, D. J., Coughlan, M. P. (1976) Biochem. J. 153, 297-307 [Medline] [Order article via Infotrieve]
  49. Trieber, C. A., Rothery, R. A., Weiner, J. A. (1994) J. Biol. Chem. 269, 7103-7109 [Abstract/Free Full Text]
  50. Vincent, S. P., Bray, R. C. (1978) Biochem. J. 171, 639-647 [Medline] [Order article via Infotrieve]
  51. Manadori, A., Cecchini, G., Shröder, I., Gunsalus, R. P., Werth, M. T., Johnson, M. K. (1992) Biochemistry 31, 2703-2712 [CrossRef][Medline] [Order article via Infotrieve]
  52. Cramer, S. P., Johnson, J. L., Rajagopalan, K. V., Sorrell, T. N. (1979) Biochem. Biophys. Res. Commun. 91, 434-439 [CrossRef][Medline] [Order article via Infotrieve]
  53. George, G. N., Kipke, C. A., Prince, R. C., Sunde, R. A., Enemark, J. H., Cramer, S. P. (1989) Biochemistry 28, 5075-5080 [CrossRef][Medline] [Order article via Infotrieve]
  54. Hille, R. (1994) Biochim. Biophys. Acta 1184, 143-169 [Medline] [Order article via Infotrieve]
  55. Barber, M. J., Coughlan, M. P., Rajagopalan, K. V., Siegel, L. M. (1982) Biochemistry 21, 3561-3568 [CrossRef][Medline] [Order article via Infotrieve]
  56. Yamamoto, I., Wada, N., Ujiye, T., Tachibana, M., Matzuzaki, M., Kajiwara, H., Watanabe, Y., Hirano, H., Okubo, A., Satoh, T., Yamazaki, S. (1995) Biosci. Biotech. Biochem. 59, 1850-1855 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
J. A. Muller and S. DasSarma
Genomic Analysis of Anaerobic Respiration in the Archaeon Halobacterium sp. Strain NRC-1: Dimethyl Sulfoxide and Trimethylamine N-Oxide as Terminal Electron Acceptors
J. Bacteriol., March 1, 2005; 187(5): 1659 - 1667.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Rothery, C. A. Trieber, and J. H. Weiner
Interactions between the Molybdenum Cofactor and Iron-Sulfur Clusters of Escherichia coli Dimethylsulfoxide Reductase
J. Biol. Chem., May 7, 1999; 274(19): 13002 - 13009.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Hilton, C. A. Temple, and K. V. Rajagopalan
Re-design of Rhodobacter sphaeroides Dimethyl Sulfoxide Reductase. ENHANCEMENT OF ADENOSINE N1-OXIDE REDUCTASE ACTIVITY
J. Biol. Chem., March 26, 1999; 274(13): 8428 - 8436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. V. Pollock and M. J. Barber
Serine 121 Is an Essential Amino Acid for Biotin Sulfoxide Reductase Functionality
J. Biol. Chem., November 3, 2000; 275(45): 35086 - 35090.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trieber, C. A.
Right arrow Articles by Weiner, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trieber, C. A.
Right arrow Articles by Weiner, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement